LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis
Europe - BIT:1CYTH - US5502411037 - Common Stock
8.427 EUR
-1.08 (-11.32%)
1CYTH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 29 industry peers in the Diversified Telecommunication Services industry. While 1CYTH seems to be doing ok healthwise, there are quite some concerns on its profitability. 1CYTH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
1CYTH had negative earnings in the past year.
1CYTH had a positive operating cash flow in the past year.
1CYTH had negative earnings in 4 of the past 5 years.
1CYTH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -3.58%, 1CYTH is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.05%, 1CYTH is doing worse than 75.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1CYTH is below the industry average of 7.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROIC | 1.05% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1.3 Margins
1CYTH has a worse Operating Margin (3.21%) than 68.97% of its industry peers.
1CYTH's Operating Margin has declined in the last couple of years.
1CYTH has a Gross Margin (47.68%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 1CYTH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% |
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CYTH is destroying value.
1CYTH has more shares outstanding than it did 1 year ago.
1CYTH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CYTH has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.03, we must say that 1CYTH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.03, 1CYTH is doing worse than 79.31% of the companies in the same industry.
The Debt to FCF ratio of 1CYTH is 19.08, which is on the high side as it means it would take 1CYTH, 19.08 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.08, 1CYTH is doing worse than 68.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Altman-Z | -0.03 |
ROIC/WACC0.17
WACC6.21%
2.3 Liquidity
1CYTH has a Current Ratio of 2.13. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
1CYTH's Current ratio of 2.13 is amongst the best of the industry. 1CYTH outperforms 96.55% of its industry peers.
1CYTH has a Quick Ratio of 2.10. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of 1CYTH (2.10) is better than 96.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
1CYTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.11%.
1CYTH shows a decrease in Revenue. In the last year, the revenue decreased by -6.50%.
The Revenue has been decreasing by -9.39% on average over the past years.
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
3.2 Future
Based on estimates for the next years, 1CYTH will show a small growth in Earnings Per Share. The EPS will grow by 5.71% on average per year.
Based on estimates for the next years, 1CYTH will show a decrease in Revenue. The Revenue will decrease by -2.87% on average per year.
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for 1CYTH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1CYTH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1CYTH.
62.07% of the companies in the same industry are more expensive than 1CYTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.65 | ||
| EV/EBITDA | 8.42 |
4.3 Compensation for Growth
A cheap valuation may be justified as 1CYTH's earnings are expected to decrease with -16.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
5. Dividend
5.1 Amount
1CYTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CYTH (10/31/2025, 7:00:00 PM)
8.427
-1.08 (-11.32%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners71.63%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap8.65B
Revenue(TTM)12.82B
Net Income(TTM)-1179000000
Analysts71
Price Target4.64 (-44.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.47%
Min EPS beat(2)52.11%
Max EPS beat(2)88.84%
EPS beat(4)3
Avg EPS beat(4)91.86%
Min EPS beat(4)-45.54%
Max EPS beat(4)272.03%
EPS beat(8)4
Avg EPS beat(8)-65.72%
EPS beat(12)7
Avg EPS beat(12)-22.95%
EPS beat(16)9
Avg EPS beat(16)-14.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.16%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)1
Avg Revenue beat(16)-1.51%
PT rev (1m)6.11%
PT rev (3m)7.88%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)19.7%
EPS NY rev (1m)-3.19%
EPS NY rev (3m)33%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.78 | ||
| P/FCF | 10.65 | ||
| P/OCF | 2.28 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.42 |
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)0.79
FCFY9.39%
OCF(TTM)3.7
OCFY43.9%
SpS10.82
BVpS-0.5
TBVpS-4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.58% | ||
| ROE | N/A | ||
| ROCE | 1.4% | ||
| ROIC | 1.05% | ||
| ROICexc | 1.11% | ||
| ROICexgc | 1.33% | ||
| OM | 3.21% | ||
| PM (TTM) | N/A | ||
| GM | 47.68% | ||
| FCFM | 7.31% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexgc growth 3Y-47.53%
ROICexgc growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 19.08 | ||
| Debt/EBITDA | 5.36 | ||
| Cap/Depr | 120.27% | ||
| Cap/Sales | 26.88% | ||
| Interest Coverage | 0.31 | ||
| Cash Conversion | 133.77% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | -0.03 |
F-Score5
WACC6.21%
ROIC/WACC0.17
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.92%
EPS Next Y-223.49%
EPS Next 2Y-68.31%
EPS Next 3Y-16.48%
EPS Next 5Y5.71%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-5.39%
Revenue Next Year-4.81%
Revenue Next 2Y-5.15%
Revenue Next 3Y-4.24%
Revenue Next 5Y-2.87%
EBIT growth 1Y-28.35%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year399.42%
EBIT Next 3Y75.15%
EBIT Next 5Y39.88%
FCF growth 1Y243.21%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y78.32%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%
LUMEN TECHNOLOGIES INC / 1CYTH.MI FAQ
What is the ChartMill fundamental rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to 1CYTH.MI.
What is the valuation status of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to LUMEN TECHNOLOGIES INC (1CYTH.MI). This can be considered as Overvalued.
What is the profitability of 1CYTH stock?
LUMEN TECHNOLOGIES INC (1CYTH.MI) has a profitability rating of 1 / 10.
What is the financial health of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
The financial health rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) is 4 / 10.
Can you provide the expected EPS growth for 1CYTH stock?
The Earnings per Share (EPS) of LUMEN TECHNOLOGIES INC (1CYTH.MI) is expected to decline by -223.49% in the next year.